SCHEMBL13692158

SCHEMBL13692158

CCc1ccc(C(=O)OCCN2CCN(CC(=O)OCC(=O)[C@@]3(O)CCC4C5CCC6=CC(=O)CC[C@]6(C)C5[C@@H](O)C[C@@]43C)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 10/20 0.62
▸ SMN1; SMN2 Q16637 3/20 0.62
▸ PGR P06401 3/20 0.62
▸ SERPINA6 P08185 2/20 0.62
▸ LMNA P02545 2/20 0.62
▸ AR P10275 2/20 0.62
▸ CHRM1 P11229 2/20 0.62
▸ MAPT P10636 2/20 0.62
▸ POLB P06746 1/20 0.62
▸ GAA P10253 1/20 0.62
▸ CYP3A4 P08684 2/20 0.61
▸ NFKB1 P19838 2/20 0.61
▸ PMP22 Q01453 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ NR3C1 P04150 6/20 0.56
▸ NR3C2 P08235 3/20 0.56
▸ CYP2C19 P33261 2/20 0.56
▸ HSD17B10 Q99714 2/20 0.56
▸ SHBG P04278 1/20 0.56
▸ KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13694252 0.93 HIF1A (0.58) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13692224 0.88 PGR (0.63) HIF1APGRSERPINA6LMNAAR
SCHEMBL13692170 0.87 HIF1A (0.76) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13694229 0.85 HIF1A (0.67) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL4097766 0.83 HIF1A (0.75) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL4091523 0.83 PGR (0.61) HIF1APGRSERPINA6LMNAAR
SCHEMBL13692155 0.83 HIF1A (0.79) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL18278997 0.82 HIF1A (0.80) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13694233 0.81 HIF1A (0.58) HIF1APGRSERPINA6LMNAAR
SCHEMBL13694193 0.81 HIF1A (0.71) HIF1ASMN1; SMN2PGRSERPINA6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221543-A1 NEW CORTICOSTEROIDS NICOX S A. (FR) 2009-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221543-A1 NEW CORTICOSTEROIDS CYP11B1, NR3C1, NR3C2 HIF1A 1741/4885SMN1; SMN2 4258/4885PGR 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback